Neri D - Search Results

1

A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors.

Rotta G, Gilardoni E, Ravazza D, Mock J, Seehusen F, Elsayed A, Puca E, De Luca R, Pellegrino C, Look T, Weiss T, Manz MG, Halin C, Neri D, Dakhel Plaza S. Rotta G, et al. Among authors: neri d. EMBO Mol Med. 2024 Apr;16(4):904-926. doi: 10.1038/s44321-024-00034-0. Epub 2024 Mar 6. EMBO Mol Med. 2024. PMID: 38448543 Free PMC article.

2

Antibody-Based targeting of angiogenesis.

Halin C, Neri D. Halin C, et al. Among authors: neri d. Crit Rev Ther Drug Carrier Syst. 2001;18(3):299-339. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11442202 Review.

3

Antibody-based targeting of angiogenesis.

Halin C, Zardi L, Neri D. Halin C, et al. Among authors: neri d. News Physiol Sci. 2001 Aug;16:191-4. doi: 10.1152/physiologyonline.2001.16.4.191. News Physiol Sci. 2001. PMID: 11479371 Review.

4

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

Halin C, Rondini S, Nilsson F, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Nat Biotechnol. 2002 Mar;20(3):264-9. doi: 10.1038/nbt0302-264. Nat Biotechnol. 2002. PMID: 11875427

5

Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides.

Niesner U, Halin C, Lozzi L, Günthert M, Neri P, Wunderli-Allenspach H, Zardi L, Neri D. Niesner U, et al. Among authors: neri p, neri d. Bioconjug Chem. 2002 Jul-Aug;13(4):729-36. doi: 10.1021/bc025517+. Bioconjug Chem. 2002. PMID: 12121127

6

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.

Halin C, Niesner U, Villani ME, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Int J Cancer. 2002 Nov 10;102(2):109-16. doi: 10.1002/ijc.10674. Int J Cancer. 2002. PMID: 12385005

7

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

Melkko S, Halin C, Borsi L, Zardi L, Neri D. Melkko S, et al. Among authors: neri d. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1485-90. doi: 10.1016/s0360-3016(02)03927-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459375

8

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Cancer Res. 2003 Jun 15;63(12):3202-10. Cancer Res. 2003. PMID: 12810649

9

A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.

Strassberger V, Gutbrodt KL, Krall N, Roesli C, Takizawa H, Manz MG, Fugmann T, Neri D. Strassberger V, et al. Among authors: neri d. J Proteomics. 2014 Mar 17;99:138-51. doi: 10.1016/j.jprot.2014.01.022. Epub 2014 Jan 30. J Proteomics. 2014. PMID: 24487095

10

Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation.

Hemmerle T, Zgraggen S, Matasci M, Halin C, Detmar M, Neri D. Hemmerle T, et al. Among authors: neri d. J Dermatol Sci. 2014 Nov;76(2):96-103. doi: 10.1016/j.jdermsci.2014.07.012. Epub 2014 Aug 15. J Dermatol Sci. 2014. PMID: 25190364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters